Seeking Alpha
More on GERN by Beacon Asset Managers
Latest GERN Articles
-
Wednesday Options Recap
December 2, 2009 • Frederic Ruffy
-
BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?
October 29, 2009 • Mike Havrilla
-
Columbus Day Dash and Slash: DepoMed, Vivus, Oncolytics and RadNet
October 12, 2009 • M. E. Garza
-
Stock Watch: BDSI, ACTC.PK, ONTY
October 11, 2009 • VFC's Stock House
-
Cramer's Lightning Round - Energy Transfer Partners Is an Armored Stock (10/1/09)
October 2, 2009 • SA Editor Miriam Metzinger
-
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
September 20, 2009 • Justin M. Hall
-
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
September 11, 2009 • Justin M. Hall
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.











Geron Corporation (GERN)
Posts on GERN by Beacon Asset Managers
Geron Share Price Pushes Higher on GE Healthcare Alliance
Geron's Risk-Reward Profile Best in Biotech?
Posts on GERN by other instabloggers
-
December 02, 2009
•
Penn Bioinvestor
-
November 01, 2009
•
M. E. Garza
-
October 21, 2009
•
stocknerd
-
September 18, 2009
•
Justin M. Hall
-
September 11, 2009
•
Justin M. Hall
All instablog posts on GERN »Obama Says Yes to Stem Cells: StemCells Inc, Opexa Therapeutics and Aastrom Biosciences Shares Rally
Friday's Rx-Recap for the Health Care Sector (10-30-09)
stem cells asleep
Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up